Akèy › Sendwòm myelodisplastik › New Hampshire
Etid klinik pou Sendwòm myelodisplastik nan New Hampshire
5 etid pou Sendwòm myelodisplastik ap chèche patisipan nan sit nan New Hampshire.
Tèks ofisyèl etid la (Anglè)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT05564390Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06577441The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
Ap rekriteFaz 1/2
Jiska laj 22 · Tout sèks · Mizajou Aug 25, 2026 · NCT04726241Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
- Dartmouth-Hitchcock, Lebanon
Ap rekriteEtid obsèvasyon
Jiska laj 30 · Tout sèks · Mizajou Jul 16, 2026 · NCT04968834Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
- Dana Farber/New Hampshire Oncology-Hematology, Londonderry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2026 · NCT02269592Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.